SignPath Pharma, Inc.
PrivateLast Round
VC Round
Jul 25, 2025
Total Funding Raised
$847,500
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SignPath Pharma, Inc. is a clinical-stage biotechnology company that develops proprietary liposomal formulations of curcumin and other therapeutics to treat cancer and mitigate cardiac side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SignPath Pharma, Inc. Comparables
Compare SignPath Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bexion Pharmaceuticals | 78% | |
| ForDoz Pharma Corp. | 77% | |
| Moleculin Biotech, Inc. | 73% |
SignPath Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 25, 2025 | ||||
| Private Placement | Jul 26, 2011 | ||||
| Debt | Apr 1, 2008 |
Key People
Founding team and executive leadership
SignPath Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Wickfield Capital | VC Round |
| Loop Capital Markets LLC | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 38% MoM, reaching 2.2K.
- Apr 17, 2026
Monthly visitors grew 177% MoM, reaching 1.6K.
SignPath Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SignPath Pharma, Inc.'s valuation, stock price, and market status.
Is SignPath Pharma, Inc. a public or private company?
SignPath Pharma, Inc. is a private company.
What is the current stock price of SignPath Pharma, Inc.?
SignPath Pharma, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is SignPath Pharma, Inc. worth (valuation)?
Valuation information for SignPath Pharma, Inc. is not publicly available.
Can I buy SignPath Pharma, Inc. stock?
SignPath Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SignPath Pharma, Inc.'s last funding round?
SignPath Pharma, Inc.'s most recent funding round was VC Round on July 25, 2025.
Who are the main investors in SignPath Pharma, Inc.?
Key investors in SignPath Pharma, Inc. include The Michael J. Fox Foundation for Parkinson's Research, Loop Capital Markets LLC.
Will SignPath Pharma, Inc. IPO soon?
No public IPO plans have been announced for SignPath Pharma, Inc..
How can I track SignPath Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SignPath Pharma, Inc.'s secondary market activity and sign up for updates.